THE Pharmaceutical Society of Australia's (PSA) Faye McMillan Conference Grant has commenced for the second consecutive year, in collaboration with Care Pharmaceuticals and Hydralyte.
Named after the esteemed First Nations pharmacist, the grant is specifically tailored for Aboriginal and Torres Strait Islander pharmacists and interns.
The PSA grant will support attendance at the upcoming PSA National Conference, covering full conference registration, travel, and accommodation.
McMillan, a pioneer in the field, holds the distinction of being the first Indigenous Australian to obtain a western degree in pharmacy.
Her remarkable contributions to healthcare, education, and community engagement have earned her widespread recognition, including the PSA Pharmacist of the Year award in 2022 and the NSW Aboriginal Woman of the Year title in 2019.
She is also a 2023/24 Harkness Fellow and a founding member of Indigenous Allied Health Australia.
McMillan's advocacy for Indigenous healthcare and inclusivity within the pharmacy profession aligns with the grant's objective of promoting pathways for First Nations pharmacists.
"While Aboriginal and Torres Strait Islander peoples comprise 3.8% of Australia's total population, the current proportion of registered pharmacists who identify as such is much lower at just 0.3%," said PSA CEO Adj A/Prof Steve Morris.
"This grant opportunity looks to support the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people," added Morris.
Care Pharmaceuticals and Hydralyte echoed this sentiment, highlighting the ongoing need to increase workforce participation.
To submit an expression of interest for the grant CLICK HERE. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Mar 24
